MedTrace Logo

Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer

NCT04835025 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-04-08

No results posted yet for this study

Summary

This is a Retrospective, Multicenter, Controlled Study to Evaluate Immunotherapy and Radiotherpay for Brain Lesions as a Potential Treatment for Patients with Brain Metastasis in non-small cell lung cancer

Conditions

  • Non Small Cell Lung Cancer

Interventions

DRUG

PD-1/PD-L1 inhibitor

In non-small cell lung cancer, patients with brain metastases received radiotherapy for brain lesions and immunotherapy (including sequential and concurrent model). Those patients would enter the trial group; After patients experiencing PD in this group, follow-up treatment until tumor progression again or death

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Wuhan University

    collaborator OTHER

  • Sun Yat-sen University

    collaborator OTHER

  • Tongji Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-12-31
Completion
2021-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04835025 on ClinicalTrials.gov